BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rovere-Querini P, Canti V, Erra R, Bianchi E, Slaviero G, D'Angelo A, Rosa S, Candiani M, Castiglioni MT. Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: A case report. Medicine (Baltimore) 2018;97:e12584. [PMID: 30290624 DOI: 10.1097/MD.0000000000012584] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Erton ZB, Erkan D. Treatment advances in antiphospholipid syndrome: 2022 update. Current Opinion in Pharmacology 2022;65:102212. [DOI: 10.1016/j.coph.2022.102212] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Soybilgic A, Avcin T. Pediatric APS: State of the Art. Curr Rheumatol Rep 2020;22:9. [PMID: 32124078 DOI: 10.1007/s11926-020-0887-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 López-benjume B, Rodríguez-pintó I, Amigo MC, Erkan D, Shoenfeld Y, Cervera R, Espinosa G. Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”. Autoimmunity Reviews 2022. [DOI: 10.1016/j.autrev.2022.103055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Alijotas-Reig J, Esteve-Valverde E, Anunciación-Llunell A, Marques-Soares J, Pardos-Gea J, Miró-Mur F. Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review. J Clin Med 2022;11:675. [PMID: 35160128 DOI: 10.3390/jcm11030675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 De Lorenzo R, Canti V, Manfredi AA, Rovere-Querini P. The immunology of the fetal-placental unit comes of age. Clin Exp Immunol 2019;198:11-4. [PMID: 31476799 DOI: 10.1111/cei.13359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chaturvedi S, Braunstein EM, Brodsky RA. Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications. J Thromb Haemost 2021;19:607-16. [PMID: 32881236 DOI: 10.1111/jth.15082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Petri M. Antiphospholipid syndrome. Transl Res 2020;225:70-81. [PMID: 32413497 DOI: 10.1016/j.trsl.2020.04.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Hoxha A, Tormene D, Campello E, Simioni P. Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature. Front Pharmacol 2022;13:849692. [DOI: 10.3389/fphar.2022.849692] [Reference Citation Analysis]
9 Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol 2021;12:621247. [PMID: 34122062 DOI: 10.3389/fphar.2021.621247] [Reference Citation Analysis]
10 Chaturvedi S, Brodsky RA, McCrae KR. Complement in the Pathophysiology of the Antiphospholipid Syndrome. Front Immunol 2019;10:449. [PMID: 30923524 DOI: 10.3389/fimmu.2019.00449] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 12.3] [Reference Citation Analysis]
11 Xie Z, Li H, Qi W, Li J, Wu C, Hu C, Jiang N, Wang Q, Tian X, Li M, Zhao J, Sui R, Zeng X. Characteristics and risk factors of retinal vasculopathy in antiphospholipid syndrome. Lupus 2022;:9612033211069762. [PMID: 35042380 DOI: 10.1177/09612033211069762] [Reference Citation Analysis]
12 McDonnell T, Wincup C, Buchholz I, Pericleous C, Giles I, Ripoll V, Cohen H, Delcea M, Rahman A. The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS. Blood Rev 2020;39:100610. [PMID: 31471128 DOI: 10.1016/j.blre.2019.100610] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
13 Stefanovic V. The Extended Use of Eculizumab in Pregnancy and Complement Activation⁻Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys-The Future Is Now? J Clin Med 2019;8:E407. [PMID: 30909646 DOI: 10.3390/jcm8030407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]